Search Results - andrew+schally

1 Results

Sort By:

Effect of GHRH Antagonists in Type 2 Diabetes and Obesity

The current state of the art Triglyceride-rich-lipoproteins (TRL), that are generated in the small intestine as chylomicrons and the liver as very-low-density lipoprotein (VLDL), and their remnants represent an important risk factor for cardiovascular disease (DVD) in people with diabetes, obesities, or metabolic syndrome. The problems with the current...

Published: 3/9/2022 | Inventor(s): Maritza Romero Lucas, Rudolf Lucas, Neal Weintraub, Andrew Schally, Renzhi Cai

Keywords(s):

Category(s): Therapeutics